BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 31444849)

  • 1. A novel spleen-dedicated stiffness measurement by FibroScan® improves the screening of high-risk oesophageal varices.
    Stefanescu H; Marasco G; Calès P; Fraquelli M; Rosselli M; Ganne-Carriè N; de Ledinghen V; Ravaioli F; Colecchia A; Rusu C; Andreone P; Mazzella G; Festi D
    Liver Int; 2020 Jan; 40(1):175-185. PubMed ID: 31444849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A combined model based on spleen stiffness measurement and Baveno VI criteria to rule out high-risk varices in advanced chronic liver disease.
    Colecchia A; Ravaioli F; Marasco G; Colli A; Dajti E; Di Biase AR; Bacchi Reggiani ML; Berzigotti A; Pinzani M; Festi D
    J Hepatol; 2018 Aug; 69(2):308-317. PubMed ID: 29729368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Baveno VI criteria and spleen stiffness measurement rule out high-risk varices in virally suppressed HBV-related cirrhosis.
    Wang H; Wen B; Chang X; Wu Q; Wen W; Zhou F; Guo Y; Ji Y; Gu Y; Lai Q; He Q; Li J; Chen J; Hou J
    J Hepatol; 2021 Mar; 74(3):584-592. PubMed ID: 33039403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-invasive prediction of esophageal varices by stiffness and platelet in non-alcoholic fatty liver disease cirrhosis.
    Petta S; Sebastiani G; Bugianesi E; Viganò M; Wong VW; Berzigotti A; Fracanzani AL; Anstee QM; Marra F; Barbara M; Calvaruso V; Cammà C; Di Marco V; Craxì A; de Ledinghen V
    J Hepatol; 2018 Oct; 69(4):878-885. PubMed ID: 29802949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Baveno VII algorithm outperformed other models in ruling out high-risk varices in individuals with HBV-related cirrhosis.
    Zhang X; Song J; Zhang Y; Wen B; Dai L; Xi R; Wu Q; Li Y; Luo X; Lan X; He Q; Luo W; Lai Q; Ji Y; Zhou L; Qi T; Liu M; Zhou F; Wen W; Li H; Liu Z; Chen Y; Zhu Y; Li J; Huang J; Cheng X; Tu M; Hou J; Wang H; Chen J
    J Hepatol; 2023 Mar; 78(3):574-583. PubMed ID: 36356684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved Applicability and Diagnostic Accuracy of the Novel Spleen-Dedicated Transient Elastography Device for High-Risk Esophageal Varices.
    Madir A; Barisic Jaman M; Milosevic M; Dinjar Kujundžić P; Grgurevic I
    Diagnostics (Basel); 2024 Mar; 14(7):. PubMed ID: 38611656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spleen and Liver Stiffness Is Positively Correlated with the Risk of Esophageal Variceal Bleeding.
    Buechter M; Kahraman A; Manka P; Gerken G; Jochum C; Canbay A; Dechêne A
    Digestion; 2016; 94(3):138-144. PubMed ID: 27756066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liver stiffness and serum markers for excluding high-risk varices in patients who do not meet Baveno VI criteria.
    Zhou H; Long J; Hu H; Tian CY; Lin SD
    World J Gastroenterol; 2019 Sep; 25(35):5323-5333. PubMed ID: 31558876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation of the Baveno VI criteria to rule out high-risk varices using hepatic shear-wave elastography.
    Castro Filho ÉC; Fernandes FF; Villela-Nogueira C; Madeira E; Barros F; Luz R; Pereira GH; Perazzo H
    Eur J Gastroenterol Hepatol; 2023 May; 35(5):559-567. PubMed ID: 36966754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spleen-dedicated stiffness measurement performed well to rule out high-risk varices in HBV-related hepatocellular carcinoma: Screening for high-risk varices in HCC.
    Cheng X; Tang Y; He Q; Song J; Wang K; Li H; Huang J; Wang W; Li J; Wang H; Tu M; Chen J; Yuan G; Kang S; Liu H; Zhang X; Luo W; Ji Y; Lan X; Zhou L; Lai Q; Luo X; Wu Q; Zhou D; Tan Y; Chen J; Zhang X
    Aliment Pharmacol Ther; 2024 Mar; 59(5):680-691. PubMed ID: 38155565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of Supersonic Shear Imaging to the Baveno VI Criteria and a Combination Model with Spleen Stiffness Measurement to Rule Out High-Risk Varices in Compensated Advanced Chronic Liver Disease.
    Cho YS; Kim Y; Sohn JH
    Ultraschall Med; 2022 Jun; 43(3):e13-e23. PubMed ID: 32434256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of Baveno VI and Expanded-Baveno VI Criteria for predicting gastroesophageal varices in patients with alcoholic and non-alcoholic fatty liver disease.
    Pizzamiglio M; Weicker A; de Terwangne C; Henrion J; Descamps OS; De Vos M
    Acta Gastroenterol Belg; 2022; 85(2):321-329. PubMed ID: 35709776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation of the Baveno VI and the expanded Baveno VI criteria to identify patients who could avoid screening endoscopy.
    Bae J; Sinn DH; Kang W; Gwak GY; Choi MS; Paik YH; Lee JH; Koh KC; Paik SW
    Liver Int; 2018 Aug; 38(8):1442-1448. PubMed ID: 29495113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Noninvasive assessment of the risk of esophageal variceal bleeding from noncirrhotic portal hypertension].
    Xu HF; Wang Y; He FL; Fan ZH; Liu H; Yang YP; Jia JD; Liu FQ; Ding HG
    Zhonghua Gan Zang Bing Za Zhi; 2022 Oct; 30(10):1092-1099. PubMed ID: 36727234
    [No Abstract]   [Full Text] [Related]  

  • 15. Baveno VI and VII criteria are not suitable for screening for large varices or clinically significant portal hypertension in patients with hepatocellular carcinoma.
    Allaire M; Campion B; Demory A; Larrey E; Wagner M; Rudler M; Roux C; Blaise L; Carrie NG; Thabut D
    Aliment Pharmacol Ther; 2023 Aug; 58(3):346-356. PubMed ID: 37300315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of Esophageal Varices by Liver Stiffness and Platelets in Persons With Human Immunodeficiency Virus Infection and Compensated Advanced Chronic Liver Disease.
    Merchante N; Saroli Palumbo C; Mazzola G; Pineda JA; Téllez F; Rivero-Juárez A; Ríos-Villegas MJ; Maurice JB; Westbrook RH; Judge R; Guaraldi G; Schepis F; Perazzo H; Rockstroh J; Boesecke C; Klein MB; Cervo A; Ghali P; Wong P; Petta S; De Ledinghen V; Macías J; Sebastiani G
    Clin Infect Dis; 2020 Dec; 71(11):2810-2817. PubMed ID: 31813962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Course of oesophageal varices and performance of noninvasive predictors following Hepatitis C Virus clearance in compensated advanced chronic liver disease.
    Giannini EG; De Maria C; Crespi M; Demarzo MG; Fazio V; Grasso A; Torre F; Bodini G; Marabotto E; Furnari M
    Eur J Clin Invest; 2020 May; 50(5):e13231. PubMed ID: 32291753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spleen Stiffness-Based Algorithms Are Superior to Baveno VI Criteria to Rule Out Varices Needing Treatment in Patients With Advanced Chronic Liver Disease.
    Vanderschueren E; Armandi A; Kwanten W; Cassiman D; Francque S; Schattenberg JM; Laleman W
    Am J Gastroenterol; 2024 Mar; ():. PubMed ID: 38502095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-invasive model for predicting high-risk esophageal varices based on liver and spleen stiffness.
    Yang LB; Gao X; Li H; Tantai XX; Chen FR; Dong L; Dang XS; Wei ZC; Liu CY; Wang Y
    World J Gastroenterol; 2023 Jul; 29(25):4072-4084. PubMed ID: 37476583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation of Baveno VII criteria and other non-invasive diagnostic algorithms for clinically significant portal hypertension in hepatitis delta.
    Jachs M; Sandmann L; Hartl L; Tergast T; Schwarz M; Bauer DJM; Balcar L; Ehrenbauer A; Hofer BS; Cornberg M; Lenzen H; Deterding K; Trauner M; Mandorfer M; Wedemeyer H; Reiberger T; Maasoumy B
    J Hepatol; 2024 Mar; ():. PubMed ID: 38479612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.